Sorafenib in locally advanced or metastatic patients with radioactive iodine-refractory differentiated thyroid cancer: The phase III DECISION trial.

Marcia S. Brose,Christopher Nutting,Barbara Jarzab,Rossella Elisei,Salvatore Siena,Lars Bastholt,Christelle de la Fouchardiere,Furio Pacini,Ralf Paschke,Young Kee Shong,Steven I. Sherman,Johannes WA Smit,John Woojune Chung, Harald Siedentop,Istvan Molnar,Martin Schlumberger

Journal of Clinical Oncology（2013）

引用 0|浏览0

暂无评分

摘要

4 The full, final text of this abstract will be available at abstract.asco.org at 7:30 AM (EDT) on Sunday, June, 2, 2013, and in the Annual Meeting Proceedings online supplement to the June 20, 2013, issue of Journal of Clinical Oncology. Onsite at the Meeting, this abstract will be printed in the Sunday edition of ASCO Daily News.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要